Default object view. Click to create a custom template, Node ID: 179614, Object ID: 107392

First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label,...

First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

Tags: Early Early , Locally advanced Locally advanced , Metastatic Metastatic

No relation

Yes

No relation

No

28/01/2017 3:31 pm

No